BD (NYSE:BDX) announced recently that it inaugurated a new $38.6 million manufacturing facility in Tijuana, Mexico. Government officials from Mexico and the state of Baja California joined in the opening of the medication management plant. BD plans for the facility to produce devices and technologies that improve medication safety within healthcare settings. According to a […]
BD
BD warns on cybersecurity risk with BodyGuard infusion pumps
The U.S. Cybersecurity and Infrastructure Security Agency (CISA) today issued an advisory regarding infusion pumps from BD (NYSE:BD). CISA’s advisory concerns the BD BodyGuard infusion pumps. They may contain a vulnerability in the form of a missing protection mechanism for an alternate hardware interface. No known public exploits specifically target this vulnerability, CISA said. Attackers […]
BD, Biocorp partner on connectivity for self-administered injectable drugs
BD (NYSE:BDX) announced that it entered into an agreement with Biocorp with the aim to use connected technology with injectable drugs. The companies seek to track adherence for self-administered drug therapies, including biologics. They plan to integrate France-based Biocorp’s Injay technology with BD’s UltraSafe Plus passive needle guard. Biocorp designed Injay to capture and transmit […]
BD names new president of medication delivery
BD (NYSE:BDX) announced today that it named Eric Borin as its president of medication delivery solutions (MDS). Borin, 55, succeeds Rick Byrd in the role. Byrd recently received a promotion to EVP and president of BD’s interventional segment. As president of medication delivery solutions, Borin will report to Mike Garrison, EVP and president of the […]
BD launches next-gen prefillable vaccine syringe
BD (NYSE:BDX) announced today that it launched its next-generation glass prefillable syringe (PFS) for vaccine delivery. Franklin Lakes, New Jersey-based BD’s new Effivax syringe features tightened specifications for processability, cosmetics, contamination and integrity. The company designed it in collaboration with top pharmaceutical firms to meet the evolving needs of vaccine manufacturing. “As biopharmaceutical companies continue […]
Analysts see multi-year transition to growth for Embecta
Embecta (Nasdaq:EMBC), the BD diabetes business spinoff, may take a few years to move into a growth phase, analysts say. BTIG analysts Marie Thibault and Sam Eiber wrote a report labeling Embecta as a “Neutral” option on the market. BD initially announced it would spin off its diabetes business in 2021, finally completing the move […]
BD wins patent fight against Baxter over drug-transfer system
BD (NYSE:BD) picked up a legal victory in a patent spat with Baxter (NYSE:BAX) over a system for moving drugs. A federal judge in Chicago ruled that BD’s PhaSeal system for transporting hazardous drugs between syringes and vials doesn’t infringe two patents belonging to Baxter. U.S. District Judge Joan Lefkow granted BD summary judgment on […]
Shareholder lawsuit over BD’s Alaris pumps recall moves forward
A federal judge in New Jersey is allowing part of a shareholder lawsuit to proceed against BD (NYSE: BDX) and CEO Thomas Polen over how they communicated company performance amid increasingly serious Alaris infusion pump problems. In an Aug. 11 opinion, Judge Stanley R. Chesler dismissed Industriens Pensionsforsikring’s claims against former BD CEO Vincent Forlenza […]
Embecta stock soars on first full-quarter results after BD spinoff
Embecta (Nasdaq: EMBC) today posted third-quarter results today for the first time as a BD (NYSE: BDX) spinoff, beating the consensus forecast on Wall Street. The Parsippany, New Jersey-based diabetes technology company reported profits of $62.4 million, or $1.08 per share, on sales of $291.1 million for the three months ended June 30. RELATED: How […]
BD warns on certain infusion systems due to potential leakage
BD (NYSE:BD) issued a notice in Europe to remove specific lots of its Connecta Stopcock and Nexiva with Connecta from use. In May, the Franklin Lakes, New Jersey-based company issued a product removal field safety notice and has since identified further lots which may also exhibit a reported defect. According to a notice dated July […]
